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Purpose: The long-term results of a laparoscopic resection for colorectal cancer have been reported in several studies, but 
reports on the results of laparoscopic surgery for rectal cancer are limited. We investigated the long-term outcomes, includ-
ing the five-year overall survival, disease-free survival and recurrence rate, after a laparoscopic resection for colorectal cancer.
Methods: Using prospectively collected data on 303 patients with colorectal cancer who underwent a laparoscopic resection 
between January 2001, and December 2003, we analyzed sex, age, stage, complications, hospital stay, mean operation time 
and blood loss. The overall survival rate, disease-free survival rate and recurrence rate were investigated for 271 patients who 
could be followed for more than three years.
Results: Tumor-node-metastasis (TNM) stage I cancer was present in 55 patients (18.1%), stage II in 116 patients (38.3%), 
stage III in 110 patients (36.3%), and stage IV in 22 patients (7.3%). The mean operative time was 200 minutes (range, 100 
to 535 minutes), and the mean blood loss was 97 mL (range, 20 to 1,200 mL). The mean hospital stay was 11 days and the 
mean follow-up period was 54 months. The mean numbers of resected lymph nodes were 26 and 21 in the colon and the 
rectum, respectively, and the mean distal margins were 10 and 3 cm. The overall morbidity rate was 26.1%. The local recur-
rence rates were 2.2% and 4.4% in the colon and the rectum, respectively, and the distant recurrence rates were 7.8% and 
22.5%. The five-year overall survival rates were 86.1% in the colon (stage I, 100%; stage II, 97.6%; stage III, 77.5%; stage IV, 
16.7%) and 68.8% in the rectum (stage I, 90.2%; stage II, 84.0%; stage III, 57.6; stage IV, 13.3%). The five-year disease-free 
survival rates were 89.8% in the colon (stage I, 100%; stage II, 97.7%; stage III, 74.2%) and 74.5% in the rectum (stage I, 
90.0%; stage II, 83.9%; stage III, 59.2%).
Conclusion: Laparoscopic surgery for colorectal cancer is a good alternative method to open surgery with tolerable onco-
logic long-term results.
 Keywords: Long-term outcome; Laparoscopy; Colorectal neoplasms
it is also oncologically safe, and indications for its use are expand-
ing gradually [1-3]. Nevertheless, the results of long-term follow-
up have not been reported abundantly, but recently, Clinical Out-
comes of Surgical Therapy (COST) [4-7], Conventional versus 
Laparoscopic-Assisted Surgery in Colorectal Cancer (CLASICC) 
[5], Colon Cancer Laparoscopic or Open Resection (COLOR) [6] 
and other large-scale studies have reported the outcomes, includ-
ing the three-year, the five-year and the disease-free survival rates, 
of long-term follow up after laparoscopic surgery. Nevertheless, 
outcomes for rectal cancer are not abundant, and, in large scale 
studies, were included only in the CLASICC study [5]; thus, more 
studies on rectal cancer are required [3]. We performed laparo-
scopic resections on colorectal cancer patients, including patients 
with rectal cancer, examined the long-term follow-up results, and 
INTRODUCTION
Several studies have revealed that a laparoscopic colorectal resec-
tion not only reduces postsurgical pain and the recovery time, but   
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assessed the oncological outcomes and safety of laparoscopic colorec-
tal resections. 
METHODS
Between January 2001 to December 2003, 303 patients who were 
diagnosed as having colorectal cancer and who underwent a lapa-
roscopic resection at our hospital, excluding 3 cases that were con-
verted to open abdominal surgery due to failure of end-to-end 
anastomosis devices or perforation of tumors, were included. Us-
ing prospectively collected data, we examined gender, age, disease 
stage, and postoperative complications. Local and distant metas-
tases, the five-year survival rate, and the five-year disease-free sur-
vival rate were examined in 271 patients who could be followed 
for longer than 36 months or in whom recurrence or death was 
confirmed before 36 months. The follow-up periods were calcu-
lated based on the last visit to the outpatient clinic, and for cases 
who did not visit our hospital, telephone interviews and mortality 
data from the Bureau of Statistics were used.
Postoperative chemotherapy was administered according to the 
stage. For stage II, 5-fluorouracil (5-FU) oral medications were ad-
ministered for 6 months to 1 year and for stage III, injection of 5- 
FU and leucovorin were infused continuously for 5 days; the regi-
men was repeated 6 times at 28-day intervals. Preoperative radia-
tion therapy was performed for stage T4 male patients whose le-
sions were located below the mid rectum or for cases in which 
sphincter preservation was required. Radiation therapy was per-
formed after surgery for cases whose lateral resection margin was 
positive or for cases whose resection margin was as close as within 
0.5 cm of the distal resection margin or for cases with advanced 
cancer higher than N2. Radiation therapy patients received a total 
of 4,500 cGy, 180 cGy per day for 5 weeks (25 times). Outpatient 
clinic follow-up was performed every 3 months, with blood test, 
chest X-ray and abdominal computed tomography (abdominal 
CT) being performed every 6 months for up to 3 years and colo-
noscopic examination being performed annually for up to 5 years. 
For patients with higher than stage III cancer, chest computed to-
mography was performed annually.
For statistical analysis of the overall survival rate and the disease-
free survival rate, the Kaplan-Meier method was applied using the 
SPSS ver. 11.0 (SPSS Inc., Chicago, IL, USA). Significance was val-
idated by using the log-rank test and P-values less than 0.05 was 
considered to be significant.
RESULTS
Clinical characteristics of the patient group
Of the total 303 patients, 158 (52.2%) were male, and 145 (47.9%) 
were female; their mean age was 58 years. Regarding tumor site, 
the colon was the site in 115 patients (38.0%), and the rectum was 
the site in 188 patients (62.0%). In regard to the distribution accord-
ing to the disease stage of the tumor, stage I tumors were present 
in 55 patients (18.2%), stage II in 116 patients (38.3%), stage III in 
110 patients (36.3%), and stage IV in 22 patients (7.2%). In colon 
cancer, stage II tumors were present in 53 patients, which was the 
most prevalent. In rectal cancer, stage III tumors were present in 
75 patients, which was the most prevalent (Table 1). Thirty-two 
patients (10.6%) whose outpatient follow-up was terminated within 
36 months after surgery were excluded from the analysis of sur-
vival rate and recurrence rate. Of those 32 patients, 78.1% had stage 
I and stage II tumors (9 cases [28.1%] and 16 cases [50.0%], respec-
tively), 18.8% had stage III tumors (6 patients), and 18.8% had 
stage IV tumors (1 patient). Among stage IV patients, a curative 
resection was possible for 2 patients; for the other patients, pallia-
tive treatments were performed.
In regard to the type of surgery for colon cancer patients, a right 
hemicolectomy was performed on 35 patients, a left hemicoloc-
tomy was performed on 13 patients, a transverse colectomy was 
performed on 3 patients, and an anterior resection was performed 
on 63 patients. For rectosigmoid colon cancer, a low anterior re-
section was performed on 1 patient. In rectal cancer patients, an 
anterior resection was performed on 8 patients, a low anterior re-
section was performed on 109 patients, an ultra-low anterior re-
section was performed on 40 patients, and an abdominoperineal 
Table 1. Patients’ characteristics
Colon (n = 115) Rectum (n = 188) Total (n = 303)
Sex
   Male 53 105 158 (52.1)
   Female 62   83 145 (47.9)
Mean age (yr) 58.07
TNM stage    
   I 20   35   55 (18.1)
   II 53   63 116 (38.3)
   III 35   75 110 (36.3)
   IV   7   15 22 (7.3)
Values are presented as number (%).
Table 2. Surgical procedure
Location Surgical procedure No. (%)
Colon  Right hemicolectomy     35 (11.5)
Left hemicolectomy   13 (4.3)
T-colectomy     3 (1.0)
Anterior resection     63 (20.8)
Low anterior resection     1 (0.3)
Rectum  Anterior resection      8 (2.6)
Low anterior resection 109 (2.6)
Ultra-low anterior resection     40 (36.0)
Abdominoperineal resection     31 (10.2)
Total  303 (100)Journal of The Korean Society of
Coloproctology
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resection was performed on 31 patients (Table 2).
For rectal cancer patients, preoperative chemoradiation therapy 
was performed on 6 patients, and postoperative radiation therapy 
was performed on 17 patients. Those patients included one colon 
cancer patient and 16 rectal cancer patients. One colon cancer pa-
tient received chemoradiation therapy after a tumorectomy be-
cause of an isolated tumor at the pelvic wall. Adjuvant chemother-
apy was performed on 245 patients (80.9%), intravenous chemo-
therapy was performed on 33 colon cancer patients and 66 rectal 
cancer patients. Oral administration was performed on 56 colon 
cancer patients and 90 rectal cancer patients.
 
Operative data
In colon cancer patients, the mean operation time was 180 min-
utes (range, 100 to 355 minutes), and in rectal cancer patients, it 
was 212 minutes (range, 120 to 535 minutes). The mean blood-loss 
volumes during surgery for colon and rectal cancer patients were, 
respectively, 99 mL (range 20 to 700 mL) and 96 mL (range, 30 to 
1,200 mL). The average hospital stay period was 11 days (range, 6 
to 46 days). The average follow-up period was average 54 months 
(range, 0.5 to 92 months). The average numbers of resected lymph 
nodes in colon and rectal cancer patients were 26 (range, 4 to 65) 
and 21 (range, 0 to 63), respectively. In colon and rectal cancer 
patients, the lengths of the distal resection margins were 10.1 cm 
(range, 1.5 to 41 cm) and 2.7 cm (range, 0.2 to 13.2 cm), respec-
tively. One rectal cancer patient presented with invasion to the dis-
tal or radical resection margin, with invasion toward the vagina 
(Table 3). Postoperative complications developed in 79 patients 
(26.1%) and wound infections in 28 patients (9.2%), which were 
the most prevalent. Anastomosis leakage occurred in 21 patients 
(6.9%), 6 colon cancer patients and 15 rectal cancer patients. Among 
them, 2 of the 6 colon cancer patients and 12 of the 15 rectal can-
cer patients received an ileostomy; the remaining patients improved 
with conservative treatments. The symptom of ileus developed in 
7 patients (2.3%), and most patients improved with conservative 
treatment. In one patient, a bandlysis operation was performed 
(Table 4).
Recurrence and survival rates
The five-year survival rate was examined in 271 patients who were 
followed for longer than 36 months. The recurrence rate and the 
five-year disease-free survival rate were examined in 250 patients, 
excluding stage IV patients, in order to select patients for whom a 
curative treatment had been offered. Local recurrences were shown 
in nine cases (3.6%). In two patients, recurrence occurred at the 
main incision site of the tumor extraction resection area, in five 
patients, it occurred at the pelvic wall and in two patients, it oc-
curred at the anastomosis site. Among the two patients with anas-
tomosis-site recurrence, an abdominoperineal resection was per-
formed on one patient, and conservative treatments were used for 
the other. According to the location of the tumor, two local recur-
rences developed in colon cancer patients (2.2%), and seven local 
recurrences developed in rectal cancer patients (4.4%). Concern-
ing the TNM stage, stage I cancer was present in one patient with 
anastomosis-site reccurrence, stage II cancer in three patients, and 
stage III cancer in five patients. Distant metastases occurred in 43 
of the 250 patients (17.2%) for whom the recurrence and the five-
year disease-free survival rates had been examined. Liver metas-
tasis occurred in 24 of those patients, lung metastasis in 20, lymph 
node metastasis in 5, peritoneal metastasis in 4, and brain metas-
tasis in 3. Regarding the location of the tumor, colon cancer was 
present in 7 patients (7.8%) and rectal cancer in 36 patients (22.5%). 
Concerning the distribution of the TNM stage, stage I cancer was 
Table 3. Surgical outcome
  Colon   Rectum   Total
Operation time (min)     179.8 (100-355)     212.3 (120-535)     200.0 (100-535)
Blood loss (mL)     98.8 (20-700)        95.7 (30-1,200)        96.9 (20-1,200)
Hospital stay (day) 10.6 (6-28) 11.3 (5-46) 11.3 (6-46)
Follow-up period (mo) 58.8 (2-91)    51.0 (0.5-92)    53.9 (0.5-92)
Resected lymph node  25.6 (4-65) 20.7 (0-63) 22.5 (0-65)
Distal margin (cm)    10.1 (1.5-41)         2.7 (0.2-13.2)         5.5 (0.2-13.2)
Value are presented as mean (range).
Table 4. Postoperative complication
Colon Rectum Total
Complication 30 (26.1) 49 (26.1) 79 (26.1)
   Wound infection 14 14 28
   Anastomosis leakage   6 15 21
   Intestinal obstruction   1   6   7
   Urinary difficulty   1   4   5
   Lymphatic leakage   6   1   7
   Pulmonary problem   2   4   6
   Ileostomy problem   1   5   6
   Anastomosis stricture   0   5   5
   Lt ureter transsection   1   0   1
   Port site bleeding   1   1   2
Values are presented as number (%).Journal of The Korean Society of
Coloproctology
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present 3 patients, stage II in 7 patients, and stage III in 33 patients 
(Table 5).
The five-year survival rate of all patients was 73.7%. In colon can-
cer patients, it was 86.1%, and in rectal cancer patients, it was 68.8%, 
so the five-year survival rate was shown to be lower in rectal can-
cer patients. In colon cancer patients, the five-year survival rate 
was 100% for stage I patients, 97.6% for stage II patients, 77.5% for 
stage III patients, and 16.7% for stage IV patients. In rectal cancer 
patients, the five-year survival rate was 90.2% for stage I patients, 
84.0% for stage II patients, 57.6% for stage III patients, and 13.3% 
for stage IV patients (Table 6, Fig. 1). The five-year disease-free 
survival of all patients was 80.1%. For colon cancer patients, it was 
89.8%, and for rectal cancer patients, it was 74.5%. According to 
TNM disease stage, in colon cancer patients, The five-year disease-
free survival rates were 100%, 97.7%, and 74.2% for stage I, II, and 
III patients, respectively. In rectal cancer patients, the five-year dis-
ease-free survival rates were 90.0%, 83.9%, and 59.2% for stage I, 
II, and III patients, respectively (Table 6, Fig. 2).
DISCUSSION
In colorectal cancer, laparoscopic surgery was introduced in the 
1990s. In the initial period, the recurrence rate at the incision site 
was reported to be high, and application of laparoscopic surgery 
to malignant tumors was accepted negatively. Nevertheless, with 
the development of laparoscopic equipment and its supporting 
techniques, gradually, the laparoscopic colectomy could be per-
formed safely. Recently, laparoscopic surgical methods have been 
applied frequently to malignant tumors [8-10]. In the 2000s, results 
of randomized large-scaled studies have been reported, and the 
laparoscopic colectomy was shown to be oncologically safe. Results 
of studies that examined the recurrence and the survival rates in 
long-term follow up led to its being generally accepted as oncolog-
ically safe [4-7].
In our study, long-term oncological safety was assessed by exam-
ining postoperative results, such as the resection margin, the num-
ber of resected lymph nodes, and complications, as well as the re-
currence and the survival rates of patients who were available for 
long-term follow up. The average distal resection margin was 5.59 
cm, one case showed invasion to the radical resection margin, and 
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Table 6. Oncologic outcome according to stage
Colon Rectum Total
5-yr overall survival (%)   86.1 68.8 73.7
   Stage I 100.0 90.2 93.4
   Stage II   97.6 84.0 89.9
   Stage III   77.5 57.6 63.9
   Stage IV   16.7 13.3 16.1
5-yr disease-free survival (%)   89.8 74.5 80.1
   Stage I 100.0 90.0 93.2
   Stage II   97.7 83.9 89.9
   Stage III   74.2 59.2 64.1
Table 5. Recurrence according to tumor location
Recurrence Colon Rectum Total
Local recurrence  2 (2.2) 7 (4.4) 9 (3.6)
   Wound 1   1    2
   Pelvic recur 1   1   2
   Anastomosis site 0   5   5
Distant recurrence 7 (7.8) 36 (22.5) 43 (17.2)
   Liver 4 20 24
   Lung 5 15 20
   LN 1   4   5
   Peritoneal seeding 0   4   4
   Brain  0   3   3
Values are presented as number (%).Journal of The Korean Society of
Coloproctology
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the average number of resected lymph nodes was 22.5. These find-
ings demonstrated that oncologic safety of our laparoscopic sur-
gery was comparable to open surgery or to previous results of other 
laparoscopic surgery groups [11, 12].
In the results of most studies reported recently, the recurrence 
rate after laparoscopic surgery for colorectal cancer was shown to 
be comparable to or better than that of open abdominal surgery 
[5-7, 13]. In our study, the local recurrence rates were 3.6% for all 
patients, 2.2% for all colon cancer patients and 4.4% for all rectal 
cancer patients. The distance recurrence rates were 17.2% for all 
patients, 7.8% for colon cancer patients, and 22.5% for rectal can-
cer patients. Both recurrence rates were higher when the tumor 
was located in the rectum. The results were not greatly different 
from those in the study reported by Kim et al. [14], who examined 
the recurrence rate after performing open abdominal surgery on 
colorectal cancer patients on whom a radical resection could be 
performed. In that study, the local recurrence rates were 3.1% and 
7.2% in colon cancer and rectal cancer patients, respectively. The 
distant recurrence rates were 10.5% and 17.9% in colon cancer and 
rectal cancer patients, respectively. In the CLASICC trial, which 
studied patients who were available for longer than 3 years of fol-
low up after a colorectal resection, the local recurrence in colon 
cancer patients was 7.3%, and in rectal cancer patients, it was 9.7%; 
the distant recurrence rates were 11.3%, and 18.6% in colon cancer 
and rectal cancer patients, respectively. Our results revealed that 
the total local recurrence rate and the distant recurrence rate for 
colon cancer patients were lower compared with CLASSIC trial, 
but the distant recurrence rate for rectal cancer patients was slightly 
higher. This is thought to be related to the characteristics of the 
rectal cancer patient group, in that the incidence of lower rectal 
cancer was higher than that of upper rectal cancer. In other results 
reported by Kim et al. [15] for a study conducted on rectal cancer 
patients, the distant recurrence rates in the upper, middle and lower 
rectum were 17%, 18%, and 20%, respectively, and these results 
according to the location of tumor for rectal cancer are compara-
ble to our results.
Reviewing the results of long-term follow up conducted in other 
countries, the three-year survival rates in large-scaled prospective 
studies, such as the COST study [5], the CLASICC trial [6], and 
the COLOR study [7], were 85%, 66.7%, and 84.2% for open sur-
gery and 85%, 68.4%, and 84.2% for laparoscopic surgery, respec-
tively. Among them, the CLASICC study included rectal cancer 
[6]; thus, the survival rate was lower than those of other studies. 
The COST study [5] reported that the five-year survival rate to be 
74.6% in the open surgery group and 76.4% in the laparoscopic 
surgery group, but rectal cancer was not included. In other stud-
ies, the average five-year survival rates for colon cancer treated lap-
aroscopically were 77%, 100-61.6% (stage I-III), and 65.3% [16-18, 
respectively]. In our study, the average five-year survival rate was 
73.7%, and the five-year disease-free survival rate was 80.1%, which 
are comparable to previous results for open abdominal surgery or 
to the results of other laparoscopic surgeries. Korean reports on 
long-term survival are not abundant. In regard to open abdomi-
nal surgery, in the study reported by Kim et al. [14], the five-year 
survival rate for colorectal cancer patients was shown to be 61.5%. 
In the results of Moon et al. [19], which reported the long-term 
follow-up outcomes for longer than 10 years, the average five-year 
survival rate in colorectal cancer cases was 77.6%, and the five-year 
disease-free survival rate was 77.5%. In regard to the results for 
laparoscopic surgery, in the study reported by Lee et al. [20] in 
2008, the three-year disease-free survival rate for colon cancer pa-
tients was 89.2%, and the three-year disease-free survival rate for 
rectal cancer patients was 85.7%.
In rectal cancer, in comparison with colon cancer, a noticeably 
poor survival rate or recurrence rate has been reported in many 
studies. The blood flow of the rectum is thought to be different from 
that of the colon; thus, the recurrence pattern is different. Another 
reason is that the surgery for rectal lesions is difficult because of 
the location itself. Recently, surgery outcomes for rectal cancer have 
improved greatly, which is thought to be influenced by the appli-
cation of the concept of total mesorectal excision (TME) to rectal 
surgery. In laparoscopic rectal cancer, whether a good surgical view 
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is secured and whether a TME is sufficiently achieved are thought 
to be factors that may exert influences on the outcome of long-term 
follow up after surgery for rectal cancer [21]. Although not multi-
center studies, some studies have reported the results of long-term 
follow up after laparoscopic rectal cancer resection. In the study 
reported by Lezoche et al. [22], which presented the results of long-
term follow up for an average of 78 months, the average survival 
rate was shown to be 71%. In the study reported by Sample et al. 
[17], for which the average follow-up period was 35.8 months, and 
in the study reported in Japan by Kitano et al. [23] in 2006, long-
term outcomes were reported. In regard to studies reported in Ko-
rea, in the study reported by Lee et al. [20], with an average 35- 
month follow up, after laparoscopic surgery for rectal cancer, the 
three-year disease-free survival rate was 85.7%. The average three-
year survival rate reported by us in 2006 was 88.9%, and the three-
year disease-free survival rate was 78.8% [24]. According to the 
study reported by Lee et al. [25] in 2007 for 251 rectal cancer pa-
tients with preoperative chemoradiation therapy, the five-year sur-
vival rate after open abdominal surgery was 93.0% for stage I can-
cer, 90.3% for stage II cancer, and 76.1% for stage III cancer. In our 
study of rectal cancer patients, preoperative chemoradiation ther-
apy was not common; nonetheless, the overall five-year survival 
rate was 90.2% for stage I cancer, 84.0% for stage II cancer, and 
57.6% for stage III cancer, and the local recurrence rate was 4.4%, 
which are comparable to the results of a study reported by Kim et 
al. [15], who examined long-term follow-up outcomes after open 
abdominal surgery. In addition, recently, the indications for pre-
operative chemoradiation therapy have been extended; hence, if 
preoperative or postoperative chemotherapy is administered prop-
erly, better results may be obtained. The five-year survival rate for 
laparoscopic rectal surgery in Korea has not been reported. Thus, 
this study, which included a high ratio of rectal cancer patients with 
long-term follow-up results, confirmed the safety of the laparo-
scopic resection for the treatment of rectal cancer.
Since our study was conducted only on patients for whom long-
term follow-up was possible, 32 patients (10.6%) were excluded 
from the study. Other studies that performed long-term follow up 
and assessed the outcomes have reported that follow up was inter-
rupted in 2-12% of all cases [7, 15, 16]. In our study, 78.1% of all 
patients were stage I and stage II patients; thus, patients with an 
early stage of the disease comprised a large part of the excluded 
patient population. Nevertheless, selection bias may have been 
present, so a more systemic management of the postoperative fol-
low-up protocol is required.
In this study, the long-term results for a laparoscopic colorectal 
resection over an average of 57 months, including the five-year sur-
vival rate, the five-year disease-free survival rate, and the recurrence 
rate, were acceptable in comparison with those for open abdomi-
nal surgery. Laparoscopic surgery for the treatment of colorectal 
cancer is thought to be a good alternative to open surgery, with 
tolerable oncologic long-tem results.
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